Antiphospholipid antibodies in retinal vascular occlusions. A prospective study of 75 patients.
OBJECTIVE
To assess the prevalence of antiphospholipid antibodies in patients with occlusive retinal vascular disorders.


METHODS
Seventy-five consecutive patients (44 with central retinal vein occlusions, 24 with branch venous occlusions, five with vasculitis plus branch venous occlusion, and two with arterial occlusions) were screened for antiphospholipid antibodies and compared with a control group composed of outpatients with similar systemic vascular disorders.


RESULTS
The antibody assay for one patient was positive for lupus anticoagulant and the antibody assay for three other patients was positive for anticardiolipin antibodies. These four patients had central or branch retinal vein occlusion and presented with several vascular risk factors. Comparison of the retinal vascular occlusion and the control groups showed no difference in the levels of anticardiolipin antibodies or lupus anticoagulant.


CONCLUSIONS
Antiphospholipid antibodies did not seem to be a feature of retinal vein occlusion, but in rare cases (5%) they may contribute to the occlusive phenomenon. A systematic screening does not seem to be justified, but it may be valuable to test for antiphospholipid antibodies in patients without conventional risk factors and in patients with clotting screen abnormalities, particularly if associated with lupus-like syndrome or other elements of the primary antiphospholipid syndrome.
Glacet-Bernard
A
A
University Eye Clinic of Créteil, France.
Bayani
N
N
Chretien
P
P
Cochard
C
C
Lelong
F
F
Coscas
G
G
D000328:Adult; D000368:Aged; D017153:Antibodies, Anticardiolipin / Q000032:analysis*; D016736:Antiphospholipid Syndrome / Q000276:immunology; D005260:Female; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000032:analysis*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011446:Prospective Studies; D015356:Retinal Artery Occlusion / Q000276:immunology*; D012170:Retinal Vein Occlusion / Q000276:immunology*; D012307:Risk Factors
D017153:Antibodies, Anticardiolipin; D016682:Lupus Coagulation Inhibitor